Vaccine maker Biological E. Ltd on Tuesday announced that its Covid-19 vaccine Corbevax has received a nod from the Drugs Controller General of India (DCGI) for emergency use authorisation for the 5-12-year age group. Hyderabad, April 27 (IANS) Vaccine maker Biological
The Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for children of different age groups. New Delhi, April 26 (IANS) The Drugs Controller General of India (DCGI) on Tuesday approved
New Delhi, Jan 5 (IANS) The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted “in principle” approval to Bharat Biotech to conduct “Phase III superiority study and Phase III booster dose study” trials for
New Delhi, Nov 24 (IANS) Pharma major Zydus Cadila has sought approval from the Drug Controller General of India, the apex drug regulator, for a new drug named Desidustat. Desidustat is an oral alternative to injectable erythropoietin-stimulating agents (ESAs) for the
New Delhi, Oct 26 (IANS) Serum Institute of India (SII) on Monday sought regular marketing authorisation for Covid vaccine, Covishield from Drugs Controller General of India (DCGI). The application sent to the DCGI said that SII has already submitted phase-3 clinical
New Delhi, Sep 15 The Drugs Controller General of India (DCGI) has granted permission for the conducting of the Phase III bridging trials of Sputnik Light on the Indian population. The Sputnik Light is a single-dose Covid-19 vaccine of the
New Delhi, Aug 27 The Drug Controller General of India has approved the Phase 2 and 3 clinical trials of India’s first Covid-19 mRNA vaccine. Pune-based pharma major Gennova Biopharmaceuticals Ltd is developing the nation’s first mRNA-based Covid-19 vaccine. It
Bengaluru, Aug 23 The Central government and the Drugs Controller General of India (DCGI) may give approval to the Covaxin vaccines for children soon for emergency use, sources said. The administration of two doses of vaccination has been completed among
New Delhi, May 13 The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of Covaxin (Covid vaccine) in the age group of two to 18-years-old to its manufacturer Bharat Biotech Ltd, Union Health
New Delhi, Jan 15 In a major shift of narrative, the government has now disapproved the authorisation of Bharat Biotech’s Covid vaccine to people below 18 years of age whereas earlier, it was approved for children above the age of
New Delhi, Jan 2 A committee of experts assessing the coronavirus vaccines has called Hyderabad-based Bharat Biotech for a meeting at 1.30 pm on Saturday, a day after the firm was asked to present more data on its ‘Covaxin’ to
Hyderabad, Aug 5 Hyderabad-based Zenara Pharma on Wednesday announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and sell Favipiravir tablets as a treatment option for patients with mild to moderate symptoms of
 |
 |
 |
|---|---|---|
 |
 |
 |
 |
 |
 |
